NEOADJUVANT COMBINATION THERAPY OF DOCETAXEL AND COMPLETE ANDROGEN DEPRIVATION FOR LOCALIZED HIGH RISK PROSTATE CANCER BEFORE RADICAL PROSTATECTOMY

被引：0
|
作者：
Thalgott, M. K. [1 ]
Treiber, U. [1 ]
Maurer, T. [1 ]
Heck, M. [1 ]
Eiber, M. [2 ,3 ]
Reimer, B. [1 ]
Herkommer, K. [1 ]
Paul, R.
Retz, M. [1 ]
Gschwend, J. E. [1 ]
Kuebler, H. [1 ]
机构：
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Urol, D-8000 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-8000 Munich, Germany
[3] Urol Ctr Furstenfeldbruck Germering, Dept Urol, Munich, Germany
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2010年 / 9卷 / 02期
关键词：
D O I：
10.1016/S1569-9056(10)60675-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：226 / 226
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer
    Febbo, PG
    Richie, JP
    George, DJ
    Loda, M
    Manola, J
    Shankar, S
    Barnes, AS
    Tempany, C
    Catalona, W
    Kantoff, PW
    Oh, WK
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (14) : 5233 - 5240
  • [2] Androgen deprivation in combination with radical prostatectomy for localized prostate cancer
    Naito, S
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2001, 8 (07) : S19 - S21
  • [3] Impact of therapy on cancer metabolism in high-risk localized prostate cancer treated with neoadjuvant docetaxel and androgen deprivation therapy
    Qu, Feng
    Gu, Yue
    Xue, Mengxia
    He, Mingzhe
    Zhou, Fang
    Wang, Guangji
    Peng, Ying
    [J]. PROSTATE, 2021, 81 (09): : 560 - 571
  • [4] Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer
    Hennenfent, BR
    [J]. BRITISH JOURNAL OF UROLOGY, 1998, 82 (01): : 166 - 166
  • [5] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer
    Chi, Kim N.
    Chin, Joseph L.
    Winquist, Eric
    Klotz, Laurence
    Saad, Fred
    Gleave, Martin E.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (02): : 565 - 570
  • [6] Neoadjuvant therapy before radical prostatectomy in high-risk localized prostate cancer: defining appropriate endpoints
    Oh, WK
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2003, 21 (03) : 229 - 234
  • [7] Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer - Comment
    Mohler, James L.
    [J]. JOURNAL OF UROLOGY, 2008, 180 (02): : 570 - 570
  • [8] Re: Multicenter Phase II Study of Combined Neoadjuvant Docetaxel and Hormone Therapy before Radical Prostatectomy for Patients with High Risk Localized Prostate Cancer
    Beuzeboc, P.
    [J]. EUROPEAN UROLOGY, 2009, 55 (04) : 992 - 992
  • [9] Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
    Gaëtan Devos
    Wout Devlies
    Gert De Meerleer
    Marcella Baldewijns
    Thomas Gevaert
    Lisa Moris
    Daimantas Milonas
    Hendrik Van Poppel
    Charlien Berghen
    Wouter Everaerts
    Frank Claessens
    Steven Joniau
    [J]. Nature Reviews Urology, 2021, 18 : 739 - 762
  • [10] Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer
    Devos, Gaetan
    Devlies, Wout
    De Meerleer, Gert
    Baldewijns, Marcella
    Gevaert, Thomas
    Moris, Lisa
    Milonas, Daimantas
    Van Poppel, Hendrik
    Berghen, Charlien
    Everaerts, Wouter
    Claessens, Frank
    Joniau, Steven
    [J]. NATURE REVIEWS UROLOGY, 2021, 18 (12) : 739 - 762
12345